Trials / Conditions / Diffuse Large B Cell Lymphoma Relapsed
Diffuse Large B Cell Lymphoma Relapsed
6 registered clinical trials studyying Diffuse Large B Cell Lymphoma Relapsed — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas NCT07478848 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Recruiting | A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy NCT07188558 | Lyell Immunopharma, Inc. | Phase 3 |
| Recruiting | A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relap NCT06703892 | GenomeFrontier Therapeutics TW Co., Ltd. | Phase 1 |
| Recruiting | A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL NCT06789159 | Thomas Jefferson University | Phase 1 |
| Recruiting | Immunotherapy in Lymphoma NCT06796517 | Sung-Soo Park | — |
| Completed | Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cel NCT02142049 | Pharmacyclics LLC. | Phase 1 / Phase 2 |